Literature DB >> 20189109

Affinity reagents that target a specific inactive form of protein kinases.

Pratistha Ranjitkar1, Amanda M Brock, Dustin J Maly.   

Abstract

A number of small-molecule inhibitors have been developed that target the catalytic domains of protein kinases that are not in an active conformation. An inactive form that has been observed in several kinases is the DFG-out conformation. This conformation is characterized by an almost 180 degrees rotation of the conserved Asp-Phe-Gly (DFG) motif in the ATP-binding cleft relative to the active form. However, the sequence and structural determinants that allow a kinase to stably adopt the DFG-out conformation are not known. Here, we characterize a series of inhibitors based on a general pharmacophore for this inactive form. We demonstrate that modified versions of these inhibitors can be used to study the thermodynamics and kinetics of ligand binding to DFG-out-adopting kinases and for enriching these kinases from complex protein mixtures. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20189109      PMCID: PMC2871157          DOI: 10.1016/j.chembiol.2010.01.008

Source DB:  PubMed          Journal:  Chem Biol        ISSN: 1074-5521


  44 in total

1.  Discovery of aminoquinazolines as potent, orally bioavailable inhibitors of Lck: synthesis, SAR, and in vivo anti-inflammatory activity.

Authors:  Erin F DiMauro; John Newcomb; Joseph J Nunes; Jean E Bemis; Christina Boucher; John L Buchanan; William H Buckner; Victor J Cee; Lilly Chai; Holly L Deak; Linda F Epstein; Ted Faust; Paul Gallant; Stephanie D Geuns-Meyer; Anu Gore; Yan Gu; Brad Henkle; Brian L Hodous; Faye Hsieh; Xin Huang; Joseph L Kim; Josie H Lee; Matthew W Martin; Craig E Masse; David C McGowan; Daniela Metz; Deanna Mohn; Kurt A Morgenstern; Antonio Oliveira-dos-Santos; Vinod F Patel; David Powers; Paul E Rose; Stephen Schneider; Susan A Tomlinson; Yan-Yan Tudor; Susan M Turci; Andrew A Welcher; Ryan D White; Huilin Zhao; Li Zhu; Xiaotian Zhu
Journal:  J Med Chem       Date:  2006-09-21       Impact factor: 7.446

2.  Proteomics analysis of protein kinases by target class-selective prefractionation and tandem mass spectrometry.

Authors:  Josef Wissing; Lothar Jänsch; Manfred Nimtz; Guido Dieterich; Renate Hornberger; György Kéri; Jürgen Wehland; Henrik Daub
Journal:  Mol Cell Proteomics       Date:  2006-12-27       Impact factor: 5.911

Review 3.  Protein-protein interactions in the allosteric regulation of protein kinases.

Authors:  Patricia Pellicena; John Kuriyan
Journal:  Curr Opin Struct Biol       Date:  2006-10-31       Impact factor: 6.809

4.  Surface comparison of active and inactive protein kinases identifies a conserved activation mechanism.

Authors:  Alexandr P Kornev; Nina M Haste; Susan S Taylor; Lynn F Ten Eyck
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-09       Impact factor: 11.205

5.  Evolution of a highly selective and potent 2-(pyridin-2-yl)-1,3,5-triazine Tie-2 kinase inhibitor.

Authors:  Brian L Hodous; Stephanie D Geuns-Meyer; Paul E Hughes; Brian K Albrecht; Steve Bellon; James Bready; Sean Caenepeel; Victor J Cee; Stuart C Chaffee; Angela Coxon; Maurice Emery; Jenne Fretland; Paul Gallant; Yan Gu; Doug Hoffman; Rebecca E Johnson; Richard Kendall; Joseph L Kim; Alexander M Long; Michael Morrison; Philip R Olivieri; Vinod F Patel; Anthony Polverino; Paul Rose; Paul Tempest; Ling Wang; Douglas A Whittington; Huilin Zhao
Journal:  J Med Chem       Date:  2007-01-25       Impact factor: 7.446

6.  A small molecule-kinase interaction map for clinical kinase inhibitors.

Authors:  Miles A Fabian; William H Biggs; Daniel K Treiber; Corey E Atteridge; Mihai D Azimioara; Michael G Benedetti; Todd A Carter; Pietro Ciceri; Philip T Edeen; Mark Floyd; Julia M Ford; Margaret Galvin; Jay L Gerlach; Robert M Grotzfeld; Sanna Herrgard; Darren E Insko; Michael A Insko; Andiliy G Lai; Jean-Michel Lélias; Shamal A Mehta; Zdravko V Milanov; Anne Marie Velasco; Lisa M Wodicka; Hitesh K Patel; Patrick P Zarrinkar; David J Lockhart
Journal:  Nat Biotechnol       Date:  2005-02-13       Impact factor: 54.908

7.  A general strategy for creating "inactive-conformation" abl inhibitors.

Authors:  Barun Okram; Advait Nagle; Francisco J Adrián; Christian Lee; Pingda Ren; Xia Wang; Taebo Sim; Yongping Xie; Xing Wang; Gang Xia; Glen Spraggon; Markus Warmuth; Yi Liu; Nathanael S Gray
Journal:  Chem Biol       Date:  2006-07

8.  Rational design of inhibitors that bind to inactive kinase conformations.

Authors:  Yi Liu; Nathanael S Gray
Journal:  Nat Chem Biol       Date:  2006-07       Impact factor: 15.040

9.  c-Src binds to the cancer drug imatinib with an inactive Abl/c-Kit conformation and a distributed thermodynamic penalty.

Authors:  Markus A Seeliger; Bhushan Nagar; Filipp Frank; Xiaoxian Cao; M Nidanie Henderson; John Kuriyan
Journal:  Structure       Date:  2007-03       Impact factor: 5.006

10.  Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl.

Authors:  Ellen Weisberg; Paul W Manley; Werner Breitenstein; Josef Brüggen; Sandra W Cowan-Jacob; Arghya Ray; Brian Huntly; Doriano Fabbro; Gabriele Fendrich; Elizabeth Hall-Meyers; Andrew L Kung; Jürgen Mestan; George Q Daley; Linda Callahan; Laurie Catley; Cara Cavazza; Mohammad Azam; Azam Mohammed; Donna Neuberg; Renee D Wright; D Gary Gilliland; James D Griffin
Journal:  Cancer Cell       Date:  2005-02       Impact factor: 31.743

View more
  19 in total

1.  Kinobead and Single-Shot LC-MS Profiling Identifies Selective PKD Inhibitors.

Authors:  Martin Golkowski; Rama Subba Rao Vidadala; Chloe K Lombard; Hyong Won Suh; Dustin J Maly; Shao-En Ong
Journal:  J Proteome Res       Date:  2017-02-03       Impact factor: 4.466

2.  Peptoid ligands that bind selectively to phosphoproteins.

Authors:  Di Cai; A-Young Lee; Cheng-Ming Chiang; Thomas Kodadek
Journal:  Bioorg Med Chem Lett       Date:  2011-06-16       Impact factor: 2.823

3.  Sequence determinants of a specific inactive protein kinase conformation.

Authors:  Sanjay B Hari; Ethan A Merritt; Dustin J Maly
Journal:  Chem Biol       Date:  2013-06-20

4.  Conformation-Selective Analogues of Dasatinib Reveal Insight into Kinase Inhibitor Binding and Selectivity.

Authors:  Frank E Kwarcinski; Kristoffer R Brandvold; Sameer Phadke; Omar M Beleh; Taylor K Johnson; Jennifer L Meagher; Markus A Seeliger; Jeanne A Stuckey; Matthew B Soellner
Journal:  ACS Chem Biol       Date:  2016-03-01       Impact factor: 5.100

5.  Temporal Analysis of PP2A Phosphatase Activity During Insulin Stimulation Using a Direct Activity Probe.

Authors:  Jon R Beck; Tiffany Truong; Cliff I Stains
Journal:  ACS Chem Biol       Date:  2016-11-07       Impact factor: 5.100

6.  Conformation-selective inhibitors reveal differences in the activation and phosphate-binding loops of the tyrosine kinases Abl and Src.

Authors:  Sanjay B Hari; B Gayani K Perera; Pratistha Ranjitkar; Markus A Seeliger; Dustin J Maly
Journal:  ACS Chem Biol       Date:  2013-10-29       Impact factor: 5.100

7.  Structural and Functional Analysis of the Allosteric Inhibition of IRE1α with ATP-Competitive Ligands.

Authors:  Hannah C Feldman; Michael Tong; Likun Wang; Rosa Meza-Acevedo; Theodore A Gobillot; Ivan Lebedev; Micah J Gliedt; Sanjay B Hari; Arinjay K Mitra; Bradley J Backes; Feroz R Papa; Markus A Seeliger; Dustin J Maly
Journal:  ACS Chem Biol       Date:  2016-06-09       Impact factor: 5.100

8.  A hexylchloride-based catch-and-release system for chemical proteomic applications.

Authors:  Jennifer L Brigham; B Gayani K Perera; Dustin J Maly
Journal:  ACS Chem Biol       Date:  2013-01-23       Impact factor: 5.100

9.  Affinity-based probes based on type II kinase inhibitors.

Authors:  Pratistha Ranjitkar; B Gayani K Perera; Danielle L Swaney; Daniel L Swaney; Sanjay B Hari; Eric T Larson; Ratika Krishnamurty; Ethan A Merritt; Judit Villén; Dustin J Maly
Journal:  J Am Chem Soc       Date:  2012-11-06       Impact factor: 15.419

10.  A peptide photoaffinity probe specific for the active conformation of the Abl tyrosine kinase.

Authors:  Yang Deng; Brian A Couch; Anthony J Koleske; Benjamin E Turk
Journal:  Chembiochem       Date:  2012-10-18       Impact factor: 3.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.